Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Starting retirement planning at 60 can present unique challenges. Learn how to effectively navigate this stage for a secure future.
20,891 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Geopolitical tremors surge as Iran will pick supreme leader within days. Traders weigh energy, currency, and consumer...
A nationwide policy debate over banning institutional single-family rentals risks tightening rental supply and liftin...
February delivered the first drop in health care payrolls in more than four years, signaling a shift in a market that...
A BrightEdge analysis shows google’s overviews more likely to surface negative brand signals than ChatGPT, with broad...
A once-observed signal is flashing green again: the metric that preceded every BTC rally has appeared, as negative fu...
Behind every AI breakthrough lies a power backstop. This article explains how Vertiv quietly powering every AI data c...
As drone-saturated battlefields rise, the world’s most advanced tanks drive a new era of defense spending. This repor...
As factories re-shore production in 2026, three ETFs track the trend with different tilts. Here is how AIRR, PAVE, an...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
In a market obsessed with the next big disruptor, Republic Services stands out as a reliable, cash-generating machine...
As the market eyes a 4.5% yield from the LQD ETF, investors should scrutinize BBB credit risk and rate sensitivity th...